Pcv39 - Assessment of the Budget Impact of Intravenous Ferric Carboxymaltose (Fcm) for Treating Iron Deficiency Anemia in Congestive Heart Failure Patients in Greece
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.586
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV